Center for Scientific Review; Notice of Closed Meetings, 77725-77727 [E8-30118]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 245 / Friday, December 19, 2008 / Notices
electronic comments to https://
www.regulations.gov. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the guidance
document.
FOR FURTHER INFORMATION CONTACT:
Mary Parks, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 22, rm. 3362, Silver Spring,
MD 20993–0002, 301–796–2290.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a guidance for industry entitled
‘‘Diabetes Mellitus—Evaluating
Cardiovascular Risk in New
Antidiabetic Therapies to Treat Type 2
Diabetes.’’ Diabetes mellitus is
associated with an increased risk of
cardiovascular disease. Reducing longterm cardiovascular complications in
patients with diabetes should be an
important goal of disease management.
There are compelling data in patients
with type 2 diabetes supporting a
reduced risk of microvascular
complications with improved long-term
glycemic control. This guidance makes
recommendations about how to
demonstrate that a new antidiabetic
therapy to treat type 2 diabetes is not
associated with an unacceptable
increase in cardiovascular risk.
On March 3, 2008, FDA issued the
draft guidance for industry entitled
‘‘Diabetes Mellitus: Developing Drugs
and Therapeutic Biologics for Treatment
and Prevention’’ (73 FR 11420). On July
1 and 2, 2008, the Endocrinologic and
Metabolic Drugs Advisory Committee
met to discuss the role of cardiovascular
assessment in the premarketing and
postmarketing settings for drugs and
therapeutic biologics developed for the
treatment of type 2 diabetes mellitus.
After considering the discussion at this
meeting as well as other available data
and information, we have determined
that concerns about cardiovascular risk
should be more thoroughly addressed
during drug development. We are
issuing this guidance to ensure that our
recommendations reach all sponsors
who may submit applications for
approval of drugs to treat type 2
diabetes mellitus.
We are issuing this level 1 guidance
for immediate implementation,
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
FDA is not seeking comment before
implementing this guidance because of
the need to immediately notify sponsors
with ongoing development programs of
the need to address cardiovascular risk
in ongoing drug development programs.
VerDate Aug<31>2005
17:29 Dec 18, 2008
Jkt 217001
If FDA receives comments on this
guidance, it will consider the comments
and incorporate final recommendations
into the final version of the March 2008
draft guidance.
This guidance represents the agency’s
current thinking on evaluating
cardiovascular risk in new antidiabetic
therapies to treat type 2 diabetes. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
II. The Paperwork Reduction Act of
1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR part 312 have been approved
under 0910–0014, and the collections of
information in 21 CFR part 314 have
been approved under 0910–0001.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
IV. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/cder/guidance/
index.htm or https://
www.regulations.gov.
PO 00000
Frm 00135
Fmt 4703
Sfmt 4703
77725
Dated: December 1, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–30086 Filed 12–17–08; 11:15 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Prevention,
Interventions: Alcohol, Diabetes and
Smoking.
Date: January 6, 2009.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Anna L. Riley, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7759, Bethesda, MD 20892, 301–435–
2889, rileyann@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Member
Conflicts in Microbiology.
Date: January 8–9, 2009.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Guangyong Ji, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
1146.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\19DEN1.SGM
19DEN1
77726
Federal Register / Vol. 73, No. 245 / Friday, December 19, 2008 / Notices
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, EPIC
Member Conflicts SEP.
Date: January 15, 2009.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Elisabeth Koss, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, (301) 435–
1721, kosse@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Infectious
Diseases and Microbiology Member SEP.
Date: January 21–22, 2009.
Time: 9 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Soheyla Saadi, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
0903, saadisoh@csr.nih.gov.
Name of Committee: Digestive Sciences
Integrated Review Group, Hepatobiliary
Pathophysiology Study Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Hotel & Executive
Meeting Center, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Rass M. Shayiq, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Cardiovascular
Sciences Integrated Review Group, Lung
Injury, Repair, and Remodeling Study
Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ghenima Dirami, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4112,
MSC 7814, Bethesda, MD 20892, 301–594–
1321, diramig@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Clinical Oncology
Study Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications
VerDate Aug<31>2005
17:29 Dec 18, 2008
Jkt 217001
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Malaya Chatterjee, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, chatterm@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Anterior Eye Disease Study Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Mark Hopkins
Hotel, 999 California Street, San Francisco,
CA 94108.
Contact Person: Jerry L. Taylor, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202,
MSC 7846, Bethesda, MD 20892, 301–435–
1175, taylorje@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience, Integrated
Review Group, Molecular
Neuropharmacology and Signaling Study
Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sir Francis Drake Hotel, 450 Powell
Street at Suffer, San Francisco, CA 94102.
Contact Person: Deborah L. Lewis, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7850, Bethesda, MD 20892, 301–435–
1224, lewisdeb@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience,
Integrated Review Group, Cognitive
Neuroscience Study Section.
Date: February 2, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Judith A. Finkelstein, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178,
MSC 7844, Bethesda, MD 20892, 301–435–
1249, finkelsj@csr.nih.gov.
Name of Committee: Digestive Sciences
Integrated Review Group, Gastrointestinal
Cell and Molecular Biology Study Section.
Date: February 2, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Najma Begum, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, begumn@csr.nih.gov.
Name of Committee: Cardiovascular
Sciences Integrated Review Group,
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
Atherosclerosis and Inflammation of the
Cardiovascular System Study Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Larry Pinkus, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience,
Integrated Review Group, Biological Rhythms
and Sleep Study Section.
Date: February 2, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Michael Selmanoff, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1208,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, mselmanoff@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience,
Integrated Review Group, Neurotoxicology
and Alcohol Study Section.
Date: February 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Brian Hoshaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7844, Bethesda, MD 20892, 301–435–
1033, hoshawb@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior, Integrated Review Group
Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: February 2–3, 2009.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Lee S. Mann, JD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience,
Integrated Review Group Somatosensory and
Chemosensory Systems Study Section.
Date: February 3–4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Daniel R. Kenshalo, PhD,
Scientific Review Officer, Center for
E:\FR\FM\19DEN1.SGM
19DEN1
Federal Register / Vol. 73, No. 245 / Friday, December 19, 2008 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, 301–435–
1255, kenshalod@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience,
Integrated Review Group
Neuroendocrinology, Neuroimmunology, and
Behavior Study Section.
Date: February 3–4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Michael Selmanoff, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3134,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, mselmanoff@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics, Integrated Review Group,
Molecular Genetics C Study Section.
Date: February 3–4, 2009.
Time: 8 a.m to 11 a.m.
Agenda: To review and evaluate grant
applications
Place: One Washington Circle Hotel, One
Washington Circle, Washington, DC 20037
Contact Person: Barbara Whitmarsh, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2206,
MSC 7890, Bethesda, MD 20892, 301–435–
4511, whitmarshb@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular, Biophysics Integrated
Review Group, Synthetic and Biological
Chemistry A Study Section.
Date: February 3–4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Mike Radtke, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7806, Bethesda, MD 20892, 301–435–
1728, radtkem@csr.nih.gov.
Name of Committee: Cardiovascular
Sciences Integrated Review Group,
Respiratory Integrative Biology and
Translational Research Study Section.
Date: February 3–4, 2009.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Everett E. Sinnett, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, (301) 435–
1016, sinnett@nih.gov.
Name of Committee: Infectious Diseases
and Microbiology, Integrated Review Group,
Host Interactions with Bacterial Pathogens
Study Section.
Date: February 4–5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Aug<31>2005
17:29 Dec 18, 2008
Jkt 217001
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Marian Wachtel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3208,
MSC 7858, Bethesda, MD 20892, 301–435–
1148, wachtelm@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Molecular
Genetics B Study Section.
Date: February 4–5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Richard A. Currie, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, (301) 435–
1219, currieri@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 11, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–30118 Filed 12–18–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
publication(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, Review of New
Investigators’ Grant Applications.
Date: March 17, 2009.
Time: 8 a.m. to 6 p.m.
PO 00000
Frm 00137
Fmt 4703
Sfmt 4703
77727
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, at the Chevy
Chase Pavilion, 4300 Military Road,
Washington, DC 20015.
Contact Person: Katrina L Foster, PhD,
Scientific Review Officer, National Inst on
Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm.
2019, Rockville, MD 20852, 301–443–4032,
katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: December 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–30119 Filed 12–18–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, Review of Conflicted
Applications.
Date: March 17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, At the Chevy
Chase Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm
2081, Rockville, MD 20852, 301–443–0800,
bbuzas@mail.nih.gov.
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 73, Number 245 (Friday, December 19, 2008)]
[Notices]
[Pages 77725-77727]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-30118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Prevention, Interventions: Alcohol, Diabetes and
Smoking.
Date: January 6, 2009.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Anna L. Riley, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3114, MSC 7759, Bethesda, MD 20892, 301-435-
2889, rileyann@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Member Conflicts in Microbiology.
Date: January 8-9, 2009.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Guangyong Ji, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
1146.
This notice is being published less than 15 days prior to the
meeting due to the timing
[[Page 77726]]
limitations imposed by the review and funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, EPIC Member Conflicts SEP.
Date: January 15, 2009.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Elisabeth Koss, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, (301) 435-
1721, kosse@csr.nih.gov.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Infectious Diseases and Microbiology Member SEP.
Date: January 21-22, 2009.
Time: 9 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Soheyla Saadi, PhD., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
0903, saadisoh@csr.nih.gov.
Name of Committee: Digestive Sciences Integrated Review Group,
Hepatobiliary Pathophysiology Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: DoubleTree Hotel & Executive Meeting Center, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rass M. Shayiq, PhD., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 435-
2359, shayiqr@csr.nih.gov.
Name of Committee: Cardiovascular Sciences Integrated Review
Group, Lung Injury, Repair, and Remodeling Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ghenima Dirami, PhD., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4112, MSC 7814, Bethesda, MD 20892, 301-594-
1321, diramig@csr.nih.gov.
Name of Committee: Oncological Sciences Integrated Review Group,
Clinical Oncology Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Malaya Chatterjee, PhD., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 192, MSC 7804, Bethesda, MD
20892, 301-451-0131, chatterm@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Anterior Eye Disease Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: InterContinental Mark Hopkins Hotel, 999 California
Street, San Francisco, CA 94108.
Contact Person: Jerry L. Taylor, PhD., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD
20892, 301-435-1175, taylorje@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience, Integrated Review Group, Molecular Neuropharmacology
and Signaling Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sir Francis Drake Hotel, 450 Powell Street at Suffer, San
Francisco, CA 94102.
Contact Person: Deborah L. Lewis, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7850, Bethesda, MD
20892, 301-435-1224, lewisdeb@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience, Integrated Review Group, Cognitive Neuroscience Study
Section.
Date: February 2, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Judith A. Finkelstein, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178, MSC 7844, Bethesda, MD
20892, 301-435-1249, finkelsj@csr.nih.gov.
Name of Committee: Digestive Sciences Integrated Review Group,
Gastrointestinal Cell and Molecular Biology Study Section.
Date: February 2, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Najma Begum, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD 20892, 301-435-
1243, begumn@csr.nih.gov.
Name of Committee: Cardiovascular Sciences Integrated Review
Group, Atherosclerosis and Inflammation of the Cardiovascular System
Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Larry Pinkus, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
1214, pinkusl@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience, Integrated Review Group, Biological Rhythms and Sleep
Study Section.
Date: February 2, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Michael Selmanoff, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1208, MSC 7844, Bethesda, MD
20892, 301-435-1119, mselmanoff@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience, Integrated Review Group, Neurotoxicology and Alcohol
Study Section.
Date: February 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Brian Hoshaw, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5181, MSC 7844, Bethesda, MD 20892, 301-435-
1033, hoshawb@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior,
Integrated Review Group Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: February 2-3, 2009.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101.
Contact Person: Lee S. Mann, JD, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, 301-435-
0677, mannl@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience, Integrated Review Group Somatosensory and Chemosensory
Systems Study Section.
Date: February 3-4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Daniel R. Kenshalo, PhD, Scientific Review
Officer, Center for
[[Page 77727]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5182, MSC 7844, Bethesda, MD 20892, 301-435-1255,
kenshalod@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience, Integrated Review Group Neuroendocrinology,
Neuroimmunology, and Behavior Study Section.
Date: February 3-4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Michael Selmanoff, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3134, MSC 7844, Bethesda, MD
20892, 301-435-1119, mselmanoff@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics, Integrated
Review Group, Molecular Genetics C Study Section.
Date: February 3-4, 2009.
Time: 8 a.m to 11 a.m.
Agenda: To review and evaluate grant applications
Place: One Washington Circle Hotel, One Washington Circle,
Washington, DC 20037
Contact Person: Barbara Whitmarsh, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD
20892, 301-435-4511, whitmarshb@csr.nih.gov.
Name of Committee: Biological Chemistry and Macromolecular,
Biophysics Integrated Review Group, Synthetic and Biological
Chemistry A Study Section.
Date: February 3-4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westin St. Francis, 335 Powell Street, San Francisco,
CA 94102.
Contact Person: Mike Radtke, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4176, MSC 7806, Bethesda, MD 20892, 301-435-
1728, radtkem@csr.nih.gov.
Name of Committee: Cardiovascular Sciences Integrated Review
Group, Respiratory Integrative Biology and Translational Research
Study Section.
Date: February 3-4, 2009.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Everett E. Sinnett, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD
20892, (301) 435-1016, sinnett@nih.gov.
Name of Committee: Infectious Diseases and Microbiology,
Integrated Review Group, Host Interactions with Bacterial Pathogens
Study Section.
Date: February 4-5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street, NW., Washington, DC 20037.
Contact Person: Marian Wachtel, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3208, MSC 7858, Bethesda, MD 20892, 301-435-
1148, wachtelm@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Molecular Genetics B Study Section.
Date: February 4-5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
Contact Person: Richard A. Currie, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD
20892, (301) 435-1219, currieri@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 11, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-30118 Filed 12-18-08; 8:45 am]
BILLING CODE 4140-01-M
